2015 myresearch Science Internship Program: Nursing Care. Civic Education Office of Government and Community Relations

Size: px
Start display at page:

Download "2015 myresearch Science Internship Program: Nursing Care. Civic Education Office of Government and Community Relations"

Transcription

1 2015 myresearch Science Internship Program: Nursing Care Civic Education Office of Government and Community Relations

2 Mary Chudy Science Internship Program: Nursing Care

3 Patients with a Deep Brain Stimulator who Received Ketamine for Treatment Resistant Depression: A Case Study Mary Chudy Nora Finnegan, RN, BSN

4 Abstract About 50% of people do not respond to medications and therapy. Deep brain stimulation (DBS) involves sending electrical impulses to the brain. DBS, along with ketamine, are two treatments that help alleviate depressive symptoms. This study looked at 3 patients with TRD who had DBS and were being treated with ketamine. If one has an implanted DBS, ketamine infusions will not successfully treat them.

5 Background In a given year, about 14 million Americans will experience an episode of MDD. Of those that receive treatment (30%) 50% will not respond. Two+ failed treatment attempts lowers likelihood of remission. Consider diagnosis of TRD

6 Background Ketamine is a dissociative anesthetic used in veterinary medicine. In sub-anesthetic doses, it provides relief for patients with TRD. 0.5 mg/kg over 40 minutes with saline bolus following Targets the NMDA receptor complex inhibitory GABA

7 Background Deep Brain Stimulation to certain neuroanatomical sites has also been found to alleviate symptoms. Small electrical impulses trigger increased brain activity.

8 Problem/Purpose Provide clinical evidence on the efficacy of ketamine treatments in patients with DBS Explore the biochemical pathways of both ketamine and DBS in relation to each other Synthesize whether the presence of a DBS indicates or contraindicates ketamine

9 Hypothesis If ketamine patients have a pre-existing functioning deep brain stimulator then they will Respond later than patients normally would (24 hrs) Experience a lessened response to the ketamine infusions Ultimately need to withdraw from the ketamine treatments due to lack of response

10 Methodology Retrospective study medical chart review on 3 patients who fit criteria Receiving/have received a series of ketamine infusions Functional, implanted DBS in use Charts compared to those w/o DBS Indications for ketamine 2 or more failed antidepressants in 2+ classes ECT produced no response No major head trauma or psychosis

11 MADRS Score Data Treatment # Downward trend demonstrates ketamine s efficacy.

12 MADRS Score Data Patient MADRS Scores During Ketamine Treatment # Initial, transient drop in MADRS. No lasting effect.

13 Results A MADRS score of <8 maintained for 3-4 weeks= depression in remission. Pt 1: responder- 9 Pt 2: non-responder Pt 3: non-responder- 21.5

14 Conclusions Hypothesis supported by results If patient with DBS is being treated with ketamine Will experience lessened degree of alleviation Longer than average acute series Transient response Eventual regression to original state

15 Recommendations Larger sample size to further confirm these results Further research on the biochemical mechanism of deep brain stimulation Healthcare organizations educate on the possibility to treat TRD with sub-anesthetic doses of ketamine Further research on the NMDA receptor complex

16 References Bogod, N. (n.d.). Long-Term Neuropsychological Safety of Subgenual Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression. Retrieved July 13, 2015, from The Journal of Neuropsychiatry website: Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression. (n.d.). Neuropsychopharacology. (including photos slide 7, 14). lkennedy, S. (n.d.). Deep Brain Stimulation for Treatment-Resistant Depression: Follow-Up After 3 to 6 Years. Retrieved July 12, 2015, from Long-Term Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy. (n.d.). Retrieved from Neuropsychopharmacology website:

17 Special Thanks Nora Finnegan, RN, BSN Roman Dale, MD Lawre Stratton, RN The entire staff of Behavioral Health at Lutheran Hospital Nedra Starling, MA, MPH, ABD/DrPH and the Civic Education Department My amazing peer group and fellow peer mentors

18 Copyright 2015 Cleveland Clinic Foundation

2018 myresearch Science Internship Program: Health Horizons. Civic Education Office of Government and Community Relations

2018 myresearch Science Internship Program: Health Horizons. Civic Education Office of Government and Community Relations 2018 myresearch Science Internship Program: Health Horizons Civic Education Office of Government and Community Relations Amnerys Camacho Science Internship Program: Health Horizons Alternative Treatments

More information

2016 myresearch Science Internship Program: Applied Medicine. Civic Education Office of Government and Community Relations

2016 myresearch Science Internship Program: Applied Medicine. Civic Education Office of Government and Community Relations 2016 myresearch Science Internship Program: Applied Medicine Civic Education Office of Government and Community Relations Nadia Paskert Science Internship Program: Applied Medicine Breast Reconstruction

More information

2016 myresearch Science Internship Program: Radiology. Civic Education Office of Government and Community Relations

2016 myresearch Science Internship Program: Radiology. Civic Education Office of Government and Community Relations 2016 myresearch Science Internship Program: Radiology Civic Education Office of Government and Community Relations Kayla Siladi Science Internship Program: Radiology Pediatric Computed Tomography Scans

More information

2016 myresearch Science Internship Program: Laboratory Medicine. Civic Education Office of Government and Community Relations

2016 myresearch Science Internship Program: Laboratory Medicine. Civic Education Office of Government and Community Relations 2016 myresearch Science Internship Program: Laboratory Medicine Civic Education Office of Government and Community Relations Aliya Ansari Science Internship Program: Laboratory Medicine Cytologic Differentiation

More information

2013 myresearch Science Internship Program for Nursing

2013 myresearch Science Internship Program for Nursing 2013 myresearch Science Internship Program for Nursing Tamarea Townes Science Internship Program for Nursing An Investigation of Risk Factors Associated with Hypoglycemia in Adult Hospitalized Patients

More information

2014 myresearch SCIENCE Internship Program

2014 myresearch SCIENCE Internship Program 2014 myresearch SCIENCE Internship Program Maya Gaines-Smith Science Internship Program Does Mobilization of Patients With a Cancer Diagnosis Decrease Pain? Maya Gaines-Smith Marianne Douglas, MS CCC/SLP

More information

2013 myresearch Public Health Internship Program

2013 myresearch Public Health Internship Program 2013 myresearch Public Health Internship Program Joo Kim Public Health Internship Program Open Repair: Significance of Mesh Type on Inguinal Herniorrhaphy Joo Kim Richard T. Guttman Jr., MD, FACS Abstract

More information

2017 myresearch Science Internship Program: Applied Medicine. Civic Education Office of Government and Community Relations

2017 myresearch Science Internship Program: Applied Medicine. Civic Education Office of Government and Community Relations 2017 myresearch Science Internship Program: Applied Medicine Civic Education Office of Government and Community Relations Nevaeh Miller Science Internship Program: Applied Medicine A Combined Spiral CT

More information

Neural model of emotional regulation structures - Circuits involving prefrontal cortex and subcortical limbic structures - MDE associated with

Neural model of emotional regulation structures - Circuits involving prefrontal cortex and subcortical limbic structures - MDE associated with Topics Brain and signalling changes in depression Ketamine activity in refractory depression Mechanism of Action New Data Dose finding Route of Administration Activity in Other Disorders Neural model of

More information

2013 myresearch Science Internship Program

2013 myresearch Science Internship Program 2013 myresearch Science Internship Program Ryan Palko Science Internship Program Association and Frequency of Antithyroid Antibodies in Fibromyalgia Cohort at the Cleveland Clinic Ryan Palko Mehrnaz Hojjati

More information

2015 myresearch Science Internship Program: Applied Medicine. Civic Education Office of Government and Community Relations

2015 myresearch Science Internship Program: Applied Medicine. Civic Education Office of Government and Community Relations 2015 myresearch Science Internship Program: Applied Medicine Civic Education Office of Government and Community Relations Harguneet Singh Science Internship Program: Applied Medicine Comparisons of Outcomes

More information

Psychotropic Drugs in the Pipeline. Norman Sussman, M.D. Professor of Psychiatry New York University School of Medicine

Psychotropic Drugs in the Pipeline. Norman Sussman, M.D. Professor of Psychiatry New York University School of Medicine Psychotropic Drugs in the Pipeline Norman Sussman, M.D. Professor of Psychiatry New York University School of Medicine Norman Sussman, MD No Conflict of Interest to Declare Antidepressant Pipeline We need

More information

Clinical Perspective on Conducting TRD Studies. Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark

Clinical Perspective on Conducting TRD Studies. Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark Clinical Perspective on Conducting TRD Studies Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark Overview of Presentation Treatment-Resistant Depression (TRD)

More information

Brain Stimulation. Berry S. Anderson, PhD, RN Mary Rosedale, PhD, PMHNP-BC, NEA-BC Theresa Kormos, PMHCNS-BC Cindy Brown, BSN, RN

Brain Stimulation. Berry S. Anderson, PhD, RN Mary Rosedale, PhD, PMHNP-BC, NEA-BC Theresa Kormos, PMHCNS-BC Cindy Brown, BSN, RN Brain Stimulation American Psychiatric Nurses Association 24th Annual Conference October 16, 2010 Kentucky International Convention Center Louisville, Kentucky 1 Berry S. Anderson, PhD, RN Mary Rosedale,

More information

Objectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS

Objectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS Jon-Paul Khoo What is treatment resistance really? Database review 328 consecutive non-remitted MDD patients referred for private

More information

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department International Journal of Neuropsychopharmacology (2011), 14, 1127 1131. f CINP 2011 doi:10.1017/s1461145711000629 A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation

More information

Clinical Policy Title: Ketamine for treatment-resistant depression

Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Number: 00.02.13 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: January

More information

Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy

Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy Reference: NHS England xxx/x/x 1 Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy First published:

More information

Neuromodulation Approaches to Treatment Resistant Depression

Neuromodulation Approaches to Treatment Resistant Depression 1 Alternative Treatments: Neuromodulation Approaches to Treatment Resistant Depression Audrey R. Tyrka, MD, PhD Assistant Professor Brown University Department of Psychiatry Associate Chief, Mood Disorders

More information

IV Ketamine Infusions for the Treatment of Depression: An Evidence Based Practice Analysis Sergio A. Quinones, SRNA Bryan College of Health Sciences

IV Ketamine Infusions for the Treatment of Depression: An Evidence Based Practice Analysis Sergio A. Quinones, SRNA Bryan College of Health Sciences IV Ketamine Infusions for the Treatment of Depression: An Evidence Based Practice Analysis Sergio A. Quinones, SRNA Bryan College of Health Sciences Keywords: ketamine, depression, antidepressant, infusion,

More information

Department of Psychiatry AG Stimulationsverfahren in der Psychiatrie. The Role of Ketamine in Treatment-Resistant Depression

Department of Psychiatry AG Stimulationsverfahren in der Psychiatrie. The Role of Ketamine in Treatment-Resistant Depression Department of Psychiatry AG Stimulationsverfahren in der Psychiatrie The Role of Ketamine in Treatment-Resistant Depression Dr. Heiko Albrecht The Role of Ketamine in Treatment-Resistant Depression 2 Presentation

More information

Understanding Addiction: Why Can t Those Affected Just Say No?

Understanding Addiction: Why Can t Those Affected Just Say No? Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions

More information

Behavior Therapy. Therapy that applies learning principles to the elimination of unwanted behaviors.

Behavior Therapy. Therapy that applies learning principles to the elimination of unwanted behaviors. Behavior Therapy Therapy that applies learning principles to the elimination of unwanted behaviors. To treat phobias or sexual disorders, behavior therapists do not delve deeply below the surface looking

More information

Anatomy of a Neuron. Copyright 2000 by BSCS and Videodiscovery, Inc. Permission granted for classroom use. Master 2.1

Anatomy of a Neuron. Copyright 2000 by BSCS and Videodiscovery, Inc. Permission granted for classroom use. Master 2.1 Anatomy of a Neuron Master 2.1 Neurons Interact With Other Neurons Through Synapses Master 2.2 How Do Neurons Communicate? 1 2 3 4 5 6 Master 2.3 Neurons Communicate by Neurotransmission Neurons communicate

More information

Treatment Algorithm Treatment Algorithm

Treatment Algorithm Treatment Algorithm Treatment Algorithm Treatment Algorithm Primary Care Toolkit September 2015 Page 2 Adult (>18 years) Depression Flow Chart (Generic) Two Question Screen: PHQ-2 Annually, new adult patients, and when suspect

More information

#CHAIR2016. September 15 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by

#CHAIR2016. September 15 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by #CHAIR2016 September 15 17, 2016 The Biltmore Hotel Miami, FL Sponsored by #CHAIR2016 Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders Alan F. Schatzberg,

More information

Physical and Physiological Aspects of Drug Use and Abuse

Physical and Physiological Aspects of Drug Use and Abuse Question 1: What are neurons and neurotransmitters? Answer 1: A neuron is a nerve cell. It is estimated that there are 100 billion neurons in the average human brain (Levinthal, 2008). Neurons receive

More information

Epilepsy CASE 1 Localization Differential Diagnosis

Epilepsy CASE 1 Localization Differential Diagnosis 2 Epilepsy CASE 1 A 32-year-old man was observed to suddenly become unresponsive followed by four episodes of generalized tonic-clonic convulsions of the upper and lower extremities while at work. Each

More information

Frequently Asked Questions FAQS. NeuroStar TMS Therapies

Frequently Asked Questions FAQS. NeuroStar TMS Therapies Frequently Asked Questions FAQS NeuroStar TMS Therapies Provided by Dr Terrence A. Boyadjis MD 790 E Market Street Suite 245 West Chester, PA 19382 610.738.9576 FAQS About TMS Therapies Page 1 NeuroStar

More information

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the

More information

Goals for sedation during mechanical ventilation

Goals for sedation during mechanical ventilation New Uses of Old Medications Gina Riggi, PharmD, BCCCP, BCPS Clinical Pharmacist Trauma ICU Jackson Memorial Hospital Disclosure I do not have anything to disclose Objectives Describe the use of ketamine

More information

Addressing Emergency Neuro- Pharmacologic Controversies Head-On. What dose of IV benzodiazepine makes you uncomfortable?

Addressing Emergency Neuro- Pharmacologic Controversies Head-On. What dose of IV benzodiazepine makes you uncomfortable? Addressing Emergency Neuro- Pharmacologic Controversies Head-On 38 y/o 136 bpm Bryan D. Hayes @PharmERToxGuy Sz, tremor, hallucinations Which benzodiazepine would you administer first? Why? Diazepam Lorazepam

More information

Help and Healing: Section 2: Treatment Planning. Treatment and Timelines. Depression Treatment Reference. Care Team Communication

Help and Healing: Section 2: Treatment Planning. Treatment and Timelines. Depression Treatment Reference. Care Team Communication Help and Healing: Resources for Depression Care and Recovery Section 2: Treatment Planning Treatment and Timelines Depression Treatment Reference Care Team Communication Provider Education Tool - Questions

More information

Interventions for Relapsing Depression: TMS, ECT, and Ketamine

Interventions for Relapsing Depression: TMS, ECT, and Ketamine Interventions for Relapsing Depression: TMS, ECT, and Ketamine MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not

More information

Interventions for Relapsing Depression: TMS, ECT, and Ketamine

Interventions for Relapsing Depression: TMS, ECT, and Ketamine Interventions for Relapsing Depression: TMS, ECT, and Ketamine MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not

More information

Specific Care Question : Question Originator: Plain Language Summary from The Office of Evidence Based Practice: Conditional Recommendation

Specific Care Question : Question Originator: Plain Language Summary from The Office of Evidence Based Practice: Conditional Recommendation Ketorolac for Refractory Migraine in the ED Specific Care Question : In the pediatric patient diagnosed with refractory migraine is ketorolac an effective treatment? Question Originator: Migraine Therapy

More information

The Evidence Base for rtms Reimbursement

The Evidence Base for rtms Reimbursement The Evidence Base for rtms Reimbursement Bradley N. Gaynes, MD, MPH Professor of Psychiatry Associate Chair of Research Training and Education Institute of Medicine Workshop March 3, 2015 What do we know,

More information

New Research on ECT and development of neuromodulation for treatment of depression

New Research on ECT and development of neuromodulation for treatment of depression New Research on ECT and development of neuromodulation for treatment of depression Kaisa M. Hartikainen Neurologist, Academy Research Fellow, Associate Professor of Experimental Neurology Behavioral Neurology

More information

Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no Dr. Joseph Garbely Medical Director VP of Medical Services Caron Treatment Centers 1 ASAM Disclosure of Relevant Financial Relationships No Relevant Financial Relationships with Any Commercial Interests

More information

Deep Brain Stimulation for Treatment-Resistant Depression: A Review

Deep Brain Stimulation for Treatment-Resistant Depression: A Review The Open Neurosurgery Journal, 2011, 4, 1-6 1 Open Access Deep Brain Stimulation for Treatment-Resistant Depression: A Review Tatyana Sarnecki* and Yasin Temel* Departments of Neuroscience and Neurosurgery,

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary Figure 1. Behavioural effects of ketamine in non-stressed and stressed mice. Naive C57BL/6 adult male mice (n=10/group) were given a single dose of saline vehicle or ketamine (3.0 mg/kg,

More information

Results of a one-year, retrospective medication use evaluation. Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital

Results of a one-year, retrospective medication use evaluation. Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital Results of a one-year, retrospective medication use evaluation Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital Briefly review ketamine s history, mechanism of action, and unique properties

More information

Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature

Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature Drugs R D (2015) 15:37 43 DOI 10.1007/s40268-015-0081-0 REVIEW ARTICLE Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature Lael Reinstatler Nagy A. Youssef Published

More information

Carlos A. Zarate, Jr., M.D

Carlos A. Zarate, Jr., M.D Performing valid analysis in sex differences and treatment response in depression vs. Multi-modal imaging and psychiatric stress testing: A strategy for translational psychopharmacology in mood disorders

More information

The Neurobiology of Addiction

The Neurobiology of Addiction The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly

More information

Surgical Treatment of Movement Disorders. Surgical Treatment of Movement Disorders. New Techniques: Procedure is safer and better

Surgical Treatment of Movement Disorders. Surgical Treatment of Movement Disorders. New Techniques: Procedure is safer and better Surgical Treatment of Movement Stephen Grill, MD, PHD Johns Hopkins University and Parkinson s and Movement Center of Maryland Surgical Treatment of Movement Historical Aspects Preoperative Issues Surgical

More information

Life in the Fast Lane: Rapidly Acting Agents Acute Care Research

Life in the Fast Lane: Rapidly Acting Agents Acute Care Research Life in the Fast Lane: Rapidly Acting Agents Acute Care Research Cheryl McCullumsmith, MD PhD i Disclosures Consultant, Advisory Board Janssen Grants :American Foundation for Suicide Prevention Janssen

More information

MEDICAL POLICY SUBJECT: KETAMINE INFUSION THERAPY FOR THE TREATMENT OF CHRONIC PAIN SYNDROMES POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY SUBJECT: KETAMINE INFUSION THERAPY FOR THE TREATMENT OF CHRONIC PAIN SYNDROMES POLICY NUMBER: CATEGORY: Technology Assessment Clinical criteria used to make utilization review decisions are based on credible scientific evidence published in peer reviewed medical literature generally recognized by the medical community. Guidelines

More information

AP PSYCH Unit 13.3 Biomedical Therapies

AP PSYCH Unit 13.3 Biomedical Therapies AP PSYCH Unit 13.3 Biomedical Therapies Prescribed medications or medical procedures that act directly on the patient s nervous system. Drugs that alter brain chemistry Affecting brain circuitry with electric

More information

Medication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford

Medication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford Medication for Anxiety and Depression PJ Cowen Department of Psychiatry, University of Oxford Topics Medication for anxiety disorders Medication for first line depression treatment Medication for resistant

More information

The Next Chapter in Brain Stimulation Therapy

The Next Chapter in Brain Stimulation Therapy The Next Chapter in Brain Stimulation Therapy Outline I. Depression and Treatment Resistant Depression Barriers to Treatment Treatment Options Cost and Impact of Depression II. Electroconvulsive Therapy

More information

Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy (all ages) NHS England Reference: P

Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy (all ages) NHS England Reference: P Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy (all ages) NHS England Reference: 1736P NHS England INFORMATION READER BOX Directorate Medical Operations and Information

More information

SEEING KETAMINE IN A NEW LIGHT

SEEING KETAMINE IN A NEW LIGHT SEEING KETAMINE IN A NEW LIGHT BobbieJean Sweitzer, M.D., FACP Professor of Anesthesiology Director of Perioperative Medicine Northwestern University Bobbie.Sweitzer@northwestern.edu LEARNING OBJECTIVES

More information

2018 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD Lundbeck, LLC.

2018 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD Lundbeck, LLC. Neuromodulation Techniques: State of the Science Philip G. Janicak, MD Adjunct Professor Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine Consultant

More information

Anatomy of a Neuron. Copyright 2000 by BSCS and Videodiscovery, Inc. Permission granted for classroom use. Updated Master 2.

Anatomy of a Neuron. Copyright 2000 by BSCS and Videodiscovery, Inc. Permission granted for classroom use. Updated Master 2. Anatomy of a Neuron Master 2.1 Neurons Interact with Other Neurons through Synapses Master 2.2 Name Date Due Cells of the Nervous System Learning Target: Identify and state the function of the components

More information

Treatment of Depression: A Brief History

Treatment of Depression: A Brief History 2500 82nd Place Urbandale, Ia Treatment of Depression: A Brief History 1960 s to Present Community Based Services SSRI Antidepressants SNRI Antidepressants 1970 s to present 20% of patients do not respond

More information

Supplemental Data. Inclusion/exclusion criteria for major depressive disorder group and healthy control group

Supplemental Data. Inclusion/exclusion criteria for major depressive disorder group and healthy control group 1 Supplemental Data Inclusion/exclusion criteria for major depressive disorder group and healthy control group Additional inclusion criteria for the major depressive disorder group were: age of onset of

More information

Neuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.

Neuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D. Neuromodulation in Epilepsy Gregory C. Mathews, M.D., Ph.D. Disclosure There are no disclosures to share with regards to this presentation. Epilepsy Basics What is epilepsy? Partial versus generalized

More information

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year

More information

Stimulation and/or Surgical Approaches to Psychiatric Illness

Stimulation and/or Surgical Approaches to Psychiatric Illness Stimulation and/or Surgical Approaches to Psychiatric Illness Darin D. Dougherty, MD MMSc Director, Division of Neurotherapeutics Department of Psychiatry Massachusetts General Hospital Associate Professor

More information

rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies

rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies rtms Treatment Equipment rtms Equipment Positioning of coil ECT & rtms Innovative Treatment Options for Patients Only a fraction

More information

Stimulation and/or Surgical Approaches to Psychiatric Illness

Stimulation and/or Surgical Approaches to Psychiatric Illness Stimulation and/or Surgical Approaches to Psychiatric Illness Darin D. Dougherty, MD MMSc Director, Division of Neurotherapeutics Department of Psychiatry Massachusetts General Hospital Associate Professor

More information

Neurotransmitter Functioning In Major Depressive Disorder

Neurotransmitter Functioning In Major Depressive Disorder Neurotransmitter Functioning In Major Depressive Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 2017 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD January

More information

Inpatient Quality Reporting (IQR) Program

Inpatient Quality Reporting (IQR) Program Hypotension Inpatient Quality Reporting (IQR) Program SEP-1 Early Management Bundle, Severe Sepsis/ Septic Shock: v5.1 Measure Updates Questions and Answers Moderator: Candace Jackson, RN Project Lead,

More information

Repetitive Transcranial Magnetic Stimulation (rtms) and intravenous ketamine for treatment-resistant depression (TRD)

Repetitive Transcranial Magnetic Stimulation (rtms) and intravenous ketamine for treatment-resistant depression (TRD) Repetitive Transcranial Magnetic Stimulation (rtms) and intravenous ketamine for treatment-resistant depression (TRD) Docent, Senior Pychiatrist Tero Taiminen Unit of General Hospital Psychiatry Turku

More information

Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA.

Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA. Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA. Shobana Rajan, M.D. Associate staff Anesthesiologist, Cleveland Clinic, Cleveland,

More information

Psychoactive Drugs & The Brain

Psychoactive Drugs & The Brain Psychoactive Drugs & The Brain Psychoactive Substances & The Brain 1. Psychoactive substances enter the bloodstream via oral administration, inhalation, smoking, or injection 2. Psychoactive substances

More information

Ketamine in Psychiatric Practice: Taking the Long-Term View

Ketamine in Psychiatric Practice: Taking the Long-Term View Ketamine in Psychiatric Practice: Taking the Long-Term View Sanjay J. Mathew, MD Professor of Psychiatry & Behavioral Sciences Johnson Family Chair for Research in Psychiatry Menninger Department of Psychiatry

More information

Cell body, axon, dendrite, synapse

Cell body, axon, dendrite, synapse SOME BASIC NEUROSCIENCE Neurons have specialised extensions 1: Label the parts of a neuron by selecting the correct term from the box below. Cell body, axon, dendrite, synapse 1 dendrite synapse cell body

More information

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) A Neurosurgical Treatment for Parkinson s Disease Parkinson s Disease Parkinson s disease is a common neurodegenerative disorder that affects about

More information

The Neurobiology of Schizophrenia

The Neurobiology of Schizophrenia The Neurobiology of Schizophrenia Dost Ongur, MD PhD Neither I nor my spouse/partner has a relevant financial relationship with a commercial interest to disclose. What is Psychosis? Response Language Affect

More information

9/19/2018. Conflict of Interest Author Disclosure. Educational Objectives

9/19/2018. Conflict of Interest Author Disclosure. Educational Objectives Health Coaching to Increase Participation in Online Chronic Pain Management Programs: Lessons Learned Teresa Bigand, PhD-C, MSN, RN Marian Wilson, PhD, MPH, RN Mary Roberts, PhD, BSN, RN Jamie Lewis, MD

More information

Zinging the Blues. By Kathy Svitil

Zinging the Blues. By Kathy Svitil Zinging the Blues By Kathy Svitil By using magnetic or electrical stimulation to alter neural activity in the brain, neuromodulation joins medications and psychotherapy as a third domain for the treatment

More information

Barbara K. Wolicki BSN, RN Immunization Nurse Consultant MDCH Division of Immunization

Barbara K. Wolicki BSN, RN Immunization Nurse Consultant MDCH Division of Immunization Barbara K. Wolicki BSN, RN Immunization Nurse Consultant MDCH Division of Immunization WolickiB@michigan.gov Immunization Process Assess the Immunization Record Check the Recommended Schedule Ask the Screening

More information

Charles H. Kellner, MD

Charles H. Kellner, MD ECT: Learning From Recent Trials Charles H. Kellner, MD Professor, Department of Psychiatry Icahn School of Medicine at Mount Sinai ISCTM Philadelphia, PA 27 September, 2016 Charles H. Kellner, MD Disclosures

More information

Basal Ganglia. Steven McLoon Department of Neuroscience University of Minnesota

Basal Ganglia. Steven McLoon Department of Neuroscience University of Minnesota Basal Ganglia Steven McLoon Department of Neuroscience University of Minnesota 1 Course News Graduate School Discussion Wednesday, Nov 1, 11:00am MoosT 2-690 with Paul Mermelstein (invite your friends)

More information

Hallucinogens as Treatment? Preliminary Data with Ketamine. Elias Dakwar, MD Columbia University College of Physicians and Surgeons 19 October, 2017

Hallucinogens as Treatment? Preliminary Data with Ketamine. Elias Dakwar, MD Columbia University College of Physicians and Surgeons 19 October, 2017 Hallucinogens as Treatment? Preliminary Data with Ketamine Elias Dakwar, MD Columbia University College of Physicians and Surgeons 19 October, 2017 Disclosures Elias Dakwar has received funding from NIDA

More information

Action Potentials and Synaptic Transmission. BIO 219 Napa Valley College Dr. Adam Ross

Action Potentials and Synaptic Transmission. BIO 219 Napa Valley College Dr. Adam Ross Action Potentials and Synaptic Transmission BIO 219 Napa Valley College Dr. Adam Ross Review of action potentials Nodes of Ranvier Nucleus Dendrites Cell body In saltatory conduction, the nerve impulses

More information

Primary Care: Referring to Psychiatry

Primary Care: Referring to Psychiatry Primary Care: Referring to Psychiatry Carol Capitano, PhD, APRN-BC Assistant Professor, Clinical Educator University of New Mexico College of Nursing University of New Mexico Psychiatric Center Objectives

More information

The Role of Ketamine in Depression: By Mary Garner. Background: Introduction

The Role of Ketamine in Depression: By Mary Garner. Background: Introduction The Role of Ketamine in Depression: By Mary Garner Background: Introduction The average person has up to 15% lifetime risk for developing depression 13. Major depressive disorder symptoms can include a

More information

Patient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder

Patient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder Dr. Zahida Tayyib www.mvptms.com Patient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder If you are considering Brainsway Deep treatment

More information

ALCOHOL Other name(s): ethyl alcohol, ethanol, grain alcohol, hootch, liquor, booze, firewater, EtOH Class: alcohols are molecules with a hydroxyl

ALCOHOL Other name(s): ethyl alcohol, ethanol, grain alcohol, hootch, liquor, booze, firewater, EtOH Class: alcohols are molecules with a hydroxyl Other name(s): ethyl alcohol, ethanol, grain alcohol, hootch, liquor, booze, firewater, EtOH Class: alcohols are molecules with a hydroxyl (OH) bound to carbon atoms. In EtOH, the carbon is in an ethyl

More information

February 23, Q4 and Year-End 2016 Financial Results

February 23, Q4 and Year-End 2016 Financial Results February 23, 2017 Q4 and Year-End 2016 Financial Results 2 RETHINKING CNS Agenda Today s Speakers Paul Cox, Senior Director, Investor Relations Jeff Jonas, M.D., Chief Executive Officer Jim Doherty, Ph.D.,

More information

Are you not responding to antidepressants?

Are you not responding to antidepressants? PATIENTS & RELATIVES Are you not responding to antidepressants? TMS therapy might be the solution for you. Does not affect cognitive function No anesthesia Covered by most private providers Outpatient

More information

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:

More information

Lowering epilepsy-related treatment costs in the era of patient choice and value-based care

Lowering epilepsy-related treatment costs in the era of patient choice and value-based care Lowering epilepsy-related treatment costs in the era of patient choice and value-based care In-home EEG offers cost-effective, reliable alternative to traditional diagnostic services 01 Introduction One

More information

Addiction in the Brain - Latest Research. Gary M. Henschen, MD, LFAPA Chief Behavioral Health Officer Magellan Healthcare, Inc.

Addiction in the Brain - Latest Research. Gary M. Henschen, MD, LFAPA Chief Behavioral Health Officer Magellan Healthcare, Inc. Addiction in the Brain - Latest Research Gary M. Henschen, MD, LFAPA Chief Behavioral Health Officer Magellan Healthcare, Inc. The Neurobiology of Addiction About the speaker Gary M. Henschen, M.D. is

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike 3.0 License: http://creativecommons.org/licenses/by-sa/3.0/

More information

Insights. Resources for Physicians. Resources for Patients. Referrals. Revealing the Underlying Neural Mechanisms of Successful ECT

Insights. Resources for Physicians. Resources for Patients. Referrals. Revealing the Underlying Neural Mechanisms of Successful ECT The Cleveland Clinic Foundation 9500 Euclid Avenue / AC311 Cleveland, OH 44195 A publication of the Center for Behavioral Health Resources for Physicians Physician Directory View all Cleveland Clinic staff

More information

Transcranial Magnetic Stimulation for the Treatment of Depression

Transcranial Magnetic Stimulation for the Treatment of Depression Transcranial Magnetic Stimulation for the Treatment of Depression Paul E. Holtzheimer, MD Associate Professor Departments of Psychiatry and Surgery Geisel School of Medicine at Dartmouth Dartmouth-Hitchcock

More information

Delirium Monograph - Update, Spring 2014

Delirium Monograph - Update, Spring 2014 Delirium Monograph - Update, Spring 2014 Since publication of the APM monograph on Delirium in January 2012, three structured reviews have been published adding data relevant to the practice of identification,

More information

Treating Depressed Patients with Comorbid Trauma. Lori Higa BSN, RN-BC AIMS Consultant/Trainer

Treating Depressed Patients with Comorbid Trauma. Lori Higa BSN, RN-BC AIMS Consultant/Trainer Treating Depressed Patients with Comorbid Trauma Lori Higa BSN, RN-BC AIMS Consultant/Trainer Learning Objectives By the end of this training, participants should be able to: Discuss recent trends in trauma

More information

Effects of acute ketamine infusion on visual working memory encoding: a study using ERPs

Effects of acute ketamine infusion on visual working memory encoding: a study using ERPs Effects of acute ketamine infusion on visual working memory encoding: a study using ERPs Corinna Haenschel Psychology, City University London, UK Partly Funded by: the Welsh Institute of Cognitive Neuroscience

More information

When & How to Use ECT in Older Adults. Frans Hugo SJOG Midland Hospital, PERTH

When & How to Use ECT in Older Adults. Frans Hugo SJOG Midland Hospital, PERTH When & How to Use ECT in Older Adults Frans Hugo SJOG Midland Hospital, PERTH Frans.Hugo@sjog.org.au When to Use Most effective and rapid treatment for elderly with severe MDD, bipolar mania, bipolar depression

More information

Practice and Potential of Deep Brain Stimulation

Practice and Potential of Deep Brain Stimulation Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/practice-and-potential-ofdeep-brain-stimulation/3384/

More information

HealthTalks. Deep Brain Stimulation for Parkinson s Disease Patients

HealthTalks. Deep Brain Stimulation for Parkinson s Disease Patients HealthTalks Parkinson s Disease and Wellness Ali Rezai, MD Neurological Institute Director, Center for Neurological Restoration Cleveland Clinic Appointments: 216.444.4720 Deep Brain Stimulation for Parkinson

More information

The Benefits of Ketamine in the Prehospital Environment by Appropriately Trained Professionals July 2016 Sean Eaton, FP-C

The Benefits of Ketamine in the Prehospital Environment by Appropriately Trained Professionals July 2016 Sean Eaton, FP-C The Benefits of Ketamine in the Prehospital Environment by Appropriately Trained Professionals July 2016 Sean Eaton, FP-C Introduction First introduced in the 1960 s as an alternative to PCP for anesthesia

More information

substance use and mental disorders: one, the other, or both?

substance use and mental disorders: one, the other, or both? substance use and mental disorders: one, the other, or both? Stephen Strobbe, PhD, RN, PMHCNS-BC, CARN-AP Dawn Farm Education Series St. Joe s Education Center, Ypsilanti, MI Tuesday, January 27, 2015

More information